Monday, October 26, 2026 · Daily editionET --:--:--

Stopped early

Targeted Lower Extremity Joint Training

NCT00765544 · US Department of Veterans Affairs · Updated 23 Sept 2013

What is being tested
Anklebot; Lokomat
For
Multiple Sclerosis
Kind of study
Tests a treatment or device on volunteers. Phase 1 and Phase 2.
Who can join
Ages 18 years to 75 years. About 10 people. The full rules are on the registry page.
Where
United States
When
Starts or started Sept 2008, ends Sept 2008. Registered 3 Oct 2008.
Results
None posted yet.

In the researchers' words

The presence of foot drop limits normal gait. Our prior data has suggested that approximately 30% of MS patients have foot drop. Although we have observed that "task-specific" rehabilitation using the Lokomat can improve ambulation in chronic MS patients, subjects with "foot drop" have difficulty translating task-specific training to normative gait patterns over ground, despite improving speed and endurance. One of the key limitations of the Lokomat is a lack of robot-assisted training for the ankle joint. The Anklebot, an MIT-developed rehabilitation robot for the ankle, has the potential to address this. The device can move throughout three planes and train ankle flexion, extension, inversion and eversion; however, therapy with the Anklebot alone does not train the knee or hip. We plan to test whether subject foot drop and overall gait benefit more from Anklebot therapy alone or a combination of Anklebot and Lokomat.
ClinicalTrials.gov, NCT00765544

Sites

  • Providence VA Medical CenterProvidence, Rhode Island, United States